Direct patent infringement – CAR-T cells, Introduction
In the previous topic, you learned about direct infringement. Here, we’ll take a closer look at a novel cancer treatment in which the patient’s white blood cells are isolated, genetically modified, and then returned to the patient.
Please login or signup for this course to get access.